Cytokeratin Fragment 21.1 (CYFRA 21.1) is a Useful Tumor Marker in Colonic Adenocarcinoma: A Cross-sectional Study
Background: Colorectal carcinoma forms a major cause of cancer-related mortality and morbidity, while having increasing incidence, all over the world. Carcino Embryonic Antigen(CEA) is the established tumour marker for colorectal cancer, with uses in screening, pre treatment staging, post therapeuti...
Main Authors: | Meer Chisthi, Krishnakumar Kuttanchettiyar, Viswanathan Kollengode |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2022-12-01
|
Series: | Iranian Journal of Colorectal Research |
Subjects: | |
Online Access: | https://colorectalresearch.sums.ac.ir/article_48973_0b9652893d723be58cff6bc5b895a429.pdf |
Similar Items
-
Cyfra 21.1: A Useful Tumour Marker in Pancreatic Ductal Adenocarcinoma: Cross-Sectional Study
by: Krishnakumar G. Kuttanchettiyar, et al.
Published: (2024-01-01) -
Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer
by: L. Giovanella, et al.
Published: (2017-08-01) -
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
by: Milena Matuszczak, et al.
Published: (2020-05-01) -
Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
by: Chaiho Jeong, et al.
Published: (2021-02-01) -
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
by: Gian Paolo Caviglia, et al.
Published: (2020-09-01)